NEO
NeoGenomics Inc
NASDAQ: NEO · HEALTHCARE · DIAGNOSTICS & RESEARCH
$17.99
+4.17% today
Updated 2026-10-28
Market cap
$2.14B
P/E ratio
—
P/S ratio
2.83x
EPS (TTM)
$-0.39
Dividend yield
—
52W range
$7 – $20
Volume
2.1M
NeoGenomics Inc (NEO) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$17.99
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$51.87
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.5B | $0.5B | $0.6B | $0.7B | $0.7B | $0.8B | $0.9B | $1.0B | $1.1B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 10.35% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -6.77%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.